Peter Svennilson
CIK 1606074 · last filed 2023-01-17
Peter Svennilson is a corporate insider who has filed 64 SEC Form 4 insider transactions across 7 companies since 2018. The most recent filing shows the insider bought $266.0K of NGM on Jan 17, 2023. Across all open-market trades the lifetime net is −$56.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $158.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$158.34M
7
64
-$56.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Director | 11,203,333 | $1.54 | $17.25M | $72.49M | 36 | 2023-01-17 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 1,547,409 | $58.01 | $89.77M | -$43.47M | 7 | 2022-05-27 |
| ORIC | Director | 4,616,666 | $8.27 | $38.18M | $0 | 3 | 2021-06-17 |
| RVMD | Director | 705,313 | $153.87 | $108.53M | -$84.23M | 6 | 2021-04-28 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | 2,604,528 | $33.99 | $88.53M | -$1.11M | 2 | 2021-02-19 |
| NRIX | 10%+ Owner | 686,274 | $16.95 | $11.63M | $0 | 1 | 2020-07-29 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 3,102,934 | $0.03 | $99.9K | $0 | 2 | 2019-06-20 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +53,780 | $266.0K | EDGAR |
| 2022-05-27 | RAPT Therapeutics, Inc. (RAPT) Delisted | Buy (P) | +19,000 | $236.6K | EDGAR |
| 2022-05-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +1,625,310 | $4.28M | EDGAR |
| 2021-09-14 | RAPT Therapeutics, Inc. (RAPT) Delisted | Mixed | −9,853,830 | -$12.70M | EDGAR |
| 2021-06-24 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | ORIC | Grant (A) | — | $0 | EDGAR |
| 2021-04-28 | RVMD | Sell (S) | −76,410 | -$3.27M | EDGAR |
| 2021-04-12 | RVMD | Sell (S) | −70,929 | -$3.15M | EDGAR |
| 2021-04-07 | RVMD | Sell (S) | −85,668 | -$4.02M | EDGAR |
| 2021-04-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |